Pfizer (PFE) Dividend Coverage Ratio Growth (5y) (2014 - 2026)
Powered by 
Analysis
Pfizer (PFE) Dividend Coverage Ratio Growth (5y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.03 Bn | 625.27 Bn | 17.26 Bn |
| 2 | AbbVie | 441.99 Bn | 435.42 Bn | 12.70 Bn |
| 3 | Merck | 366.30 Bn | 359.16 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.55 Bn | 258.86 Bn | 11.24 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - |
| 8 | Incyte | 25.53 Bn | 20.99 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.51 Bn | 18.85 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.60 Bn | 15.21 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | -15.30% |
| Mar 29, 2026 | -13.29% |
| Sep 28, 2025 | 1.97% |
| Jun 29, 2025 | -6.28% |
| Mar 30, 2025 | -5.25% |
| Sep 29, 2024 | -22.53% |
| Jun 30, 2024 | -61.94% |
| Mar 31, 2024 | -7.09% |
| Dec 31, 2023 | -49.38% |
| Jul 2, 2023 | -12.33% |
| Apr 2, 2023 | 6.55% |
| Jul 3, 2022 | 22.34% |
| Apr 3, 2022 | 16.80% |
| Oct 3, 2021 | 30.80% |
| Jul 4, 2021 | 17.70% |
| Apr 4, 2021 | 6.47% |
| Jun 28, 2020 | 1.63% |
| Mar 29, 2020 | 3.36% |
| Dec 31, 2019 | -18.92% |
| Sep 29, 2019 | 18.81% |